Anthrax edema factor potency depends on mode of cell entry

Area of Science:

• Toxicology
• Molecular Biology
• Cell Biology

Background:

• Anthrax edema factor (EF) is a potent calmodulin-dependent adenylyl cyclase.
• EF requires anthrax protective antigen (PA) for host cell entry, forming edema toxin.
• Elevated intracellular cAMP by EF causes significant tissue damage.

Purpose of the Study:

• To investigate critical factors influencing edema toxin cell entry.
• To determine mechanisms underlying EF-mediated cellular effects.
• To assess the impact of EF domain entry on its potency.

Main Methods:

• Utilized Y1, 293T, and mouse embryonic fibroblast cell lines.
• Observed EF-induced cellular morphological changes (rounding, aggregation, detachment).
• Investigated the role of protein kinase A and Epac pathways.
• Examined cellular entry via the anthrax toxin receptor as a rate-limiting step.
• Transfected EF adenylyl cyclase domain independently of the PA-binding domain.

Main Results:

• EF induces cell rounding, aggregation, and detachment mediated by protein kinase A.
• Cellular entry via the anthrax toxin receptor is the rate-limiting step for EF effects.
• Transfecting the EF adenylyl cyclase domain enhances its potency, even without PA.
• EF-mediated cellular effects vary depending on the mode of adenylyl cyclase entry.

Conclusions:

• Cellular entry mechanism significantly influences anthrax edema factor potency and effects.
• Targeting EF cell entry is crucial for understanding and mitigating anthrax toxin damage.
• The adenylyl cyclase domain's activity is critical, but its delivery impacts overall toxicity.